ArticleHaematologica2024

Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Amber Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.